改进和实施科学,以优化初级预防中的他类药物治疗
概括
实施改进和实施科学策略显著提高了对符合条件的患者进行初级预防的他类药物治疗优化. 这项质量改善计划增强了在没有动脉样硬化心血管疾病 (ASCVD) 的成年人中使用他类药物.
科学领域:
- 提高质量 提高质量
- 实施科学 实施科学
- 预防性心脏病学 预防性心脏病学
背景情况:
- 对于美国的初级预防,他类药物治疗的处方不足,只有不到五分之一的符合条件的患者接受它.
- 在没有动脉样硬化心血管疾病 (ASCVD) 的成年人中优化他类药物用于初级预防方面存在差距.
研究的目的:
- 增强在40-75岁的符合条件的患者,没有ASCVD的初级预防中增强他类药物治疗的优化.
- 使用适应环境的实施策略,实施和评估质量改进计划.
主要方法:
- 一个住院内科诊所进行了一项质量改善计划.
- 计划-做-研究-行动循环和精益六西格玛原则被采用.
- 用ERIC分类学进行了两年时间的需求评估,障碍物识别和实施策略 (IS) 的绘制.
主要成果:
- 在脂质面板订单 (64.6%至95.5%) 和完成 (78.6%至95.3%) 中观察到显著改善.
- 完成ASCVD风险得分的比例大幅增加,从3%上升至91%.
- 在符合条件的患者队列中,他类药物治疗的优化率从34.5%上升到90%.
结论:
- 改进和实施科学方法对于识别对他类药物优化需求和障碍是有效的.
- 将实施策略映射到已识别的障碍可以显著改善他类药物用于初级预防的使用.
- 使用ERIC分类学报告实施策略,有助于在各种环境中运行这些策略.
相关概念视频
01:26Atherosclerosis III: Management
311
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
311
01:20Lipid-Lowering Drugs: Statins and Miscellaneous Agents
1.3K
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.3K
01:27Coronary Artery Disease V: Interprofessional Care
208
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
208
01:26Coronary Artery Disease IV: Preventive Measures
579
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
579
01:26Angina IV: Management
230
IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
230
01:28Acute Coronary Syndrome IV: Interprofessional Care
211
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
211